Jpmorgan Chase & Co »

Atara Biotherapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 216 14.33
2025-03-31 $1.3k 216 5.94
2024-12-31 $2.9k 216 13.31
2024-09-30 $11k 1.4k 8.13
2024-06-30 $14k 1.7k 8.50